Medicare Enrolled
Dr. Bahaeddin Shabaneh, MD
Cardiovascular Disease · Webster, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shabaneh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shabaneh? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shabaneh
Dr. Bahaeddin Shabaneh is a cardiovascular disease in Webster, TX, with 19 years in practice. Based on federal Medicare data, Dr. Shabaneh performed 3,088 Medicare services across 1,730 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shabaneh received a total of $19,885 from 58 pharmaceutical and/or device companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shabaneh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 34% volume in TX$ $19,885 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,088
Medicare services
Top 34% in TX for cardiovascular disease
1,730
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~163 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity | 1,036 | $63 | $218 |
| Office visit, established patient (30-39 min) | 489 | $91 | $329 |
| Electrocardiogram (EKG), 12-lead | 267 | $11 | $49 |
| Initial hospital admission, moderate complexity | 234 | $99 | $402 |
| Echocardiogram, transthoracic | 106 | $148 | $654 |
| Regadenoson injection (Lexiscan) for heart stress test | 101 | $37 | $141 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 97 | $10 | $60 |
| Critical care, first 30-74 min | 90 | $163 | $731 |
| EKG interpretation and report | 79 | $6 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 64 | $50 | $213 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 59 | $350 | $1,486 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 58 | $60 | $678 |
| Cardiac catheterization | 55 | $201 | $2,907 |
| Ultrasound of heart, follow-up | 41 | $19 | $347 |
| Programming of dual lead pacemaker system | 34 | $55 | $181 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 33 | $150 | $553 |
| Office visit, established patient (20-29 min) | 31 | $68 | $221 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 28 | $97 | $337 |
| Heart rhythm recording of continous external ekg over 8-15 days | 24 | $8 | $35 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 24 | $19 | $76 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $17 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $11 | $72 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 19 | $276 | $3,327 |
| New patient office visit (45-59 min) | 19 | $117 | $488 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $81 | $853 |
| Blood draw (venipuncture) | 13 | $8 | $88 |
| Ultrasound of leg arteries or artery grafts | 13 | $195 | $682 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $216 | $3,037 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.7% high complexity
13.0% medium
80.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,885
Total received (2018-2024)
Avg $2,841/year across 7 years
Top 19% in TX for cardiovascular disease
58
Companies
490
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,607 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$278 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,353
2023$2,646
2022$3,060
2021$1,568
2020$4,324
2019$3,175
2018$1,759
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,519
Bard Peripheral Vascular, Inc.
$2,800
Edwards Lifesciences Corporation
$1,509
Boston Scientific Corporation
$1,338
Novartis Pharmaceuticals Corporation
$1,035
Cardiovascular Systems Inc.
$920
Janssen Pharmaceuticals, Inc
$769
Medtronic, Inc.
$657
BARD PERIPHERAL VASCULAR, INC.
$638
Medtronic Vascular, Inc.
$618
Impulse Dynamics (USA) Inc.
$584
AstraZeneca Pharmaceuticals LP
$435
BOSTON SCIENTIFIC CORPORATION
$401
Merck Sharp & Dohme LLC
$399
ABIOMED
$398
Amgen Inc.
$353
Actelion Pharmaceuticals US, Inc.
$278
Esperion Therapeutics, Inc.
$255
PFIZER INC.
$255
Amarin Pharma Inc.
$251
Boehringer Ingelheim Pharmaceuticals, Inc.
$232
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$175
Tactile Systems Technology Inc
$167
SANOFI-AVENTIS U.S. LLC
$149
E.R. Squibb & Sons, L.L.C.
$130
Novo Nordisk Inc
$112
Inari Medical, Inc.
$107
AngioDynamics, Inc.
$100
Otsuka America Pharmaceutical, Inc.
$87
Gilead Sciences, Inc.
$87
Itamar Medical Inc
$82
Shockwave Medical, Inc
$82
Lexicon Pharmaceuticals, Inc.
$79
ZOLL Circulation Inc
$76
Chiesi USA, Inc.
$75
CARDIVA MEDICAL, INC.
$64
CVRx, Inc.
$59
ViiV Healthcare Company
$58
EMD Serono, Inc.
$56
iRhythm Technologies, Inc.
$48
Bayer HealthCare Pharmaceuticals Inc.
$43
AbbVie Inc.
$39
Lundbeck LLC
$39
Allergan, Inc.
$38
ARBOR PHARMACEUTICALS, INC.
$37
Regeneron Healthcare Solutions, Inc.
$36
Avinger Inc.
$34
ABBVIE INC.
$34
ARALEZ PHARMACEUTICALS US INC.
$22
Janssen Biotech, Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$16
Azurity Pharmaceuticals, Inc.
$16
Teleflex LLC
$15
Shionogi Inc
$14
Cook Medical LLC
$14
VYERA PHARMACEUTICALS, LLC
$13
Arbor Pharmaceuticals, Inc.
$12
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 39.4% of total payments
Associated products mentioned in payments ›
ACUITY Steerable · ADVISOR · ALPHAVAC · AMPLATZER · AMPLATZER AMULET · ANDEXXA · AVYCAZ · Advisor Catheter · Angio-Seal Vascular Closure Dev · AngioVac · Arcalyst · Assurity Pacemaker · BELSOMRA · BRILINTA · BYDUREON · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · COREVALVE EVOLUT R · CROSSER · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DALVANCE · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · DOVATO · Daraprim · EDARBYCLOR · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM MRI S-ICD · ENTRESTO · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · Fetroja · Flexitouch Plus · GENERAL VASCULAR INTERVENTION · GENERAL THERAPIES · GENERAL - VASCULAR INTERVENTION · General - Therapies · IN.PACT Admiral · INGEVITY+ · Impella · Inpefa · Interventional Products · JARDIANCE · KENGREAL · LATITUDE Communicator Power Supply · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · MitraClip System · NAVITOR · NEXLETOL · NORTHERA · OPSUMIT · OPTIMIZER · Optimizer · Optis Coronary Imaging System · Ozempic · PANTHERIS · PORTICO · PRADAXA · PRALUENT · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RESONATE EL ICD VR · Repatha · Reveal LINQ · S · SAMSCA · SAPIEN 3 Ultra RESILIA · SAVVYWIRE · SEROSTIM · SQRX PULSE GENERATOR · Sentinel · Serostim · Symtuza · Temperature Management System · Trifecta GT Tissue Heart Valve · VENASEAL · VERQUVO · VIGILANT · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · Wegovy · XACT · XARELTO · ZIO XT Patch · ZONTIVITY · Zilver PTX · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $644 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
253
Per 100K population
5.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shabaneh is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 19%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shabaneh experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Shabaneh performed 1,036 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shabaneh receive payments from pharmaceutical companies?
Yes. Dr. Shabaneh received a total of $19,885 from 58 companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shabaneh's costs compare to other cardiovascular diseases in Webster?
Dr. Shabaneh's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shabaneh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Webster
Browse cardiovascular diseases in Webster ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc..
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology